Patent Assignment
Reel/Frame 063008/0548
Assignment of Assignor's Interest
Recorded: 2023-03-16
Pages: 5
Assignor
BRIDGEBIO SERVICES INC.
Executed: 2021-09-13
Assignee
CALCILYTIX THERAPEUTICS, INC.
1800 OWENS ST., STE. C-1200, SAN FRANCISCO, CALIFORNIA, 94158
Covered Property
(1)
Treatment Methods of Triphenyl Calcilytic Compounds
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 8, 2023
From: COLLINS, MICHAEL T.; GAFNI, RACHEL I.; ROSZKO, KELLY B.L.; HARTLEY, IRIS R.
To: UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 062924/0979 →
Assignment of Assignor's Interest
Mar 16, 2023
From: ROBERTS, MARY SCOTT
To: BRIDGEBIO SERVICES INC.
Reel/Frame 063008/0512 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →